NEXT Oncology
Andrea Santos Cáceres, PhD is a scientist with experience in molecular biomedicine, clinical research, and regulatory affairs. Andrea has worked on projects related to PP2A signaling inhibition in cancer, autophagy-mediated cell death in glioma, and gene expression profile in leukemia. Andrea holds a PhD in Molecular Biosciences from Universidad Autónoma de Madrid and has completed both Master's and Bachelor's degrees in related fields. Currently, Andrea serves as a Regulatory Affairs & Start-up Specialist at NEXT Oncology.
This person is not in any offices
NEXT Oncology
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough. Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers. This is not a job for Dr. Tolcher, it is his passion.